Bartlett DL - Search Results

1

Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ, Kleiner DE, Alexander HR. Feldman AL, et al. Among authors: bartlett dl. J Clin Oncol. 2003 Dec 15;21(24):4560-7. doi: 10.1200/JCO.2003.04.150. J Clin Oncol. 2003. PMID: 14673042

2

Isolated limb perfusion for malignant melanoma.

Alexander HR Jr, Fraker DL, Bartlett DL. Alexander HR Jr, et al. Among authors: bartlett dl. Semin Surg Oncol. 1996 Nov-Dec;12(6):416-28. doi: 10.1002/(SICI)1098-2388(199611/12)12:6<416::AID-SSU7>3.0.CO;2-D. Semin Surg Oncol. 1996. PMID: 8914206 Review.

3

Laparoscopic adrenalectomy: a new standard of care.

Vargas HI, Kavoussi LR, Bartlett DL, Wagner JR, Venzon DJ, Fraker DL, Alexander HR, Linehan WM, Walther MM. Vargas HI, et al. Among authors: bartlett dl. Urology. 1997 May;49(5):673-8. doi: 10.1016/s0090-4295(97)00083-6. Urology. 1997. PMID: 9145969 Free article. Clinical Trial.

4

Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.

Ma GY, Bartlett DL, Reed E, Figg WD, Lush RM, Lee KB, Libutti SK, Alexander HR. Ma GY, et al. Among authors: bartlett dl. Cancer J Sci Am. 1997 May-Jun;3(3):174-9. Cancer J Sci Am. 1997. PMID: 9161783 Clinical Trial.

5

Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics.

Bartlett DL, Ma G, Alexander HR, Libutti SK, Fraker DL. Bartlett DL, et al. Cancer. 1997 Dec 1;80(11):2084-90. doi: 10.1002/(sici)1097-0142(19971201)80:11<2084::aid-cncr7>3.0.co;2-x. Cancer. 1997. PMID: 9392330

6

A prospective analysis of the frequency, location, and curability of ectopic (nonpancreaticoduodenal, nonnodal) gastrinoma.

Wu PC, Alexander HR, Bartlett DL, Doppman JL, Fraker DL, Norton JA, Gibril F, Fogt F, Jensen RT. Wu PC, et al. Among authors: bartlett dl. Surgery. 1997 Dec;122(6):1176-82. doi: 10.1016/s0039-6060(97)90224-5. Surgery. 1997. PMID: 9426435

7

The role of thyroid resection during reoperation for persistent or recurrent hyperparathyroidism.

Libutti SK, Bartlett DL, jaskowiak NT, Skarulis M, Marx SJ, Spiegel AM, Fraker DL, Doppman JL, Shawker TJ, Alexander HR. Libutti SK, et al. Among authors: bartlett dl. Surgery. 1997 Dec;122(6):1183-7; discussion 1187-8. doi: 10.1016/s0039-6060(97)90225-7. Surgery. 1997. PMID: 9426436

8

Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas.

Brown CK, Bartlett DL, Doppman JL, Gorden P, Libutti SK, Fraker DL, Shawker TH, Skarulis MC, Alexander HR. Brown CK, et al. Among authors: bartlett dl. Surgery. 1997 Dec;122(6):1189-93; discussion 1193-4. doi: 10.1016/s0039-6060(97)90226-9. Surgery. 1997. PMID: 9426437

9

Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver.

Alexander HR Jr, Bartlett DL, Libutti SK. Alexander HR Jr, et al. Among authors: bartlett dl. Cancer J Sci Am. 1998 Jan-Feb;4(1):2-11. Cancer J Sci Am. 1998. PMID: 9467038 Review. No abstract available.

10

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.

Alexander HR Jr, Bartlett DL, Libutti SK, Fraker DL, Moser T, Rosenberg SA. Alexander HR Jr, et al. Among authors: bartlett dl. J Clin Oncol. 1998 Apr;16(4):1479-89. doi: 10.1200/JCO.1998.16.4.1479. J Clin Oncol. 1998. PMID: 9552055 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters